IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-22: a promising candidate to inhibit viral-induced liver disease progression and hepatocellular carcinoma
Authors
Keywords
Hepatocellular carcinoma, IL-22, Liver regeneration
Journal
TUMOR BIOLOGY
Volume 37, Issue 1, Pages 105-114
Publisher
Springer Nature
Online
2015-11-06
DOI
10.1007/s13277-015-4294-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acute and Chronic Effects of IL-22 on Acetaminophen-Induced Liver Injury
- (2014) Dechun Feng et al. JOURNAL OF IMMUNOLOGY
- Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment
- (2013) Juanjuan Zhao et al. HEPATOLOGY
- Serum levels of interleukin-22 and hepatitis B core-related antigen are associated with treatment response to entecavir therapy in chronic hepatitis B
- (2013) Sadahisa Okuhara et al. HEPATOLOGY RESEARCH
- Hepatoprotective and anti-fibrotic functions of interleukin-22: Therapeutic potential for the treatment of alcoholic liver disease
- (2013) Xiaoni Kong et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course
- (2013) Sidsel Støy et al. PLoS One
- Hepatitis C Virus-Induced Mitochondrial Dysfunctions
- (2013) Charlène Brault et al. Viruses-Basel
- Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
- (2012) Xiaoni Kong et al. HEPATOLOGY
- Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target
- (2012) Hua Wang et al. International Journal of Biological Sciences
- Interleukin-22
- (2012) Paul J. Chestovich et al. TRANSPLANTATION
- Hepatoprotective effects of IL-22 on fulminant hepatic failure induced by d-galactosamine and lipopolysaccharide in mice
- (2011) Wei-wei Xing et al. CYTOKINE
- Interleukin (IL)-17/IL-22-Producing T cells Enriched Within the Liver of Patients with Chronic Hepatitis C Viral (HCV) Infection
- (2011) Richard G. Foster et al. DIGESTIVE DISEASES AND SCIENCES
- A Proinflammatory Role for Interleukin-22 in the Immune Response to Hepatitis B Virus
- (2011) Ye Zhang et al. GASTROENTEROLOGY
- Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3
- (2011) Runqiu Jiang et al. HEPATOLOGY
- In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression
- (2011) Ogyi Park et al. HEPATOLOGY
- Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of signal transducer and activator of transcription 3
- (2010) Sung Hwan Ki et al. HEPATOLOGY
- IL-22 Induces an Acute-Phase Response
- (2010) S. C. Liang et al. JOURNAL OF IMMUNOLOGY
- New Activation Modus of STAT3
- (2009) Laure Dumoutier et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence
- (2009) Barbara Rehermann JOURNAL OF CLINICAL INVESTIGATION
- Human oncogenic viruses: Hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis
- (2008) V. E. Gurtsevitch BIOCHEMISTRY-MOSCOW
- The role of interleukin-22 in hepatitis C virus infection
- (2008) Julia Dambacher et al. CYTOKINE
- Interleukin-22 Forms Dimers that are Recognized by Two Interleukin-22R1 Receptor Chains
- (2007) Mario de Oliveira Neto et al. BIOPHYSICAL JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now